159 related articles for article (PubMed ID: 27998601)
1. Multidrug resistant tuberculosis: a continuing crisis.
Burki T
Lancet Infect Dis; 2016 Dec; 16(12):1337-1338. PubMed ID: 27998601
[No Abstract] [Full Text] [Related]
2. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
[No Abstract] [Full Text] [Related]
3. The "source" of drug-resistant TB outbreaks.
van Helden PD; Victor T; Warren RM
Science; 2006 Oct; 314(5798):419-20. PubMed ID: 17053131
[No Abstract] [Full Text] [Related]
4. Dynamics of multidrug resistant tuberculosis in Veracruz, México between 2002 and 2008.
Zenteno-Cuevas R; Rubi A; Fuentes-Dominguez J; Lara-Gonzalez JL; Escobar-Mesa A
J Infect Dev Ctries; 2010 Nov; 4(11):776-8. PubMed ID: 21252458
[No Abstract] [Full Text] [Related]
5. Drug-resistant Mycobacterium tuberculosis, Taiwan.
Jou R; Chuang PC; Wu YS; Yan JJ; Luh KT
Emerg Infect Dis; 2006 May; 12(5):871-2. PubMed ID: 16710962
[No Abstract] [Full Text] [Related]
6. Infectious disease. Drug-resistant TB on the rise.
Stokstad E
Science; 2000 Mar; 287(5462):2391. PubMed ID: 10766610
[No Abstract] [Full Text] [Related]
7. [Reasons for drug-resistant tuberculosis emergence].
Tu DH
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
[No Abstract] [Full Text] [Related]
8. [The problems in the chemotherapy of tuberculosis taking into account new data on its causative organism].
Egorov AM; Sazykin IuO
Antibiot Khimioter; 2000; 45(5):3-5. PubMed ID: 10862346
[No Abstract] [Full Text] [Related]
9. Drug susceptibility profiling of tuberculous meningitis.
Nagarathna S; Rafi W; Veenakumari HB; Mani R; Satishchandra P; Chandramuki A
Int J Tuberc Lung Dis; 2008 Jan; 12(1):105-7. PubMed ID: 18173886
[TBL] [Abstract][Full Text] [Related]
10. State of the Art series on drug-resistant tuberculosis: it's time to protect fluoroquinolones.
Chiang CY
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1319. PubMed ID: 19861001
[No Abstract] [Full Text] [Related]
11. Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis.
Schön T; Juréen P; Chryssanthou E; Giske CG; Sturegård E; Kahlmeter G; Hoffner S; Angeby KA
Int J Tuberc Lung Dis; 2011 Apr; 15(4):502-9. PubMed ID: 21396210
[TBL] [Abstract][Full Text] [Related]
12. Tuberculosis drug resistance: summary report for 2003.
Can Commun Dis Rep; 2004 May; 30(10):93-5. PubMed ID: 15174496
[No Abstract] [Full Text] [Related]
13. Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories.
Van Deun A; Wright A; Zignol M; Weyer K; Rieder HL
Int J Tuberc Lung Dis; 2011 Jan; 15(1):116-24. PubMed ID: 21276307
[TBL] [Abstract][Full Text] [Related]
14. Totally drug-resistant and extremely drug-resistant tuberculosis: the same disease?
Migliori GB; Centis R; D'Ambrosio L; Spanevello A; Borroni E; Cirillo DM; Sotgiu G
Clin Infect Dis; 2012 May; 54(9):1379-80. PubMed ID: 22492321
[No Abstract] [Full Text] [Related]
15. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives.
Rattan A; Kalia A; Ahmad N
Emerg Infect Dis; 1998; 4(2):195-209. PubMed ID: 9621190
[TBL] [Abstract][Full Text] [Related]
16. Will molecular diagnosis of drug-resistant tuberculosis improve patient outcomes?
Jonsson G; Furin J
Int J Tuberc Lung Dis; 2012 Jan; 16(1):4-5. PubMed ID: 22236840
[No Abstract] [Full Text] [Related]
17. The surprising diversity of Mycobacterium tuberculosis: change you can believe in.
Fortune SM
J Infect Dis; 2012 Dec; 206(11):1642-4. PubMed ID: 22984117
[No Abstract] [Full Text] [Related]
18. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis].
Zierski M
Tuberkuloza; 1966; 18(1-3):300-6. PubMed ID: 16296101
[No Abstract] [Full Text] [Related]
19. New generation methods for drug susceptibility testing for tuberculosis.
Katoch VM
Indian J Tuberc; 2008 Apr; 55(2):61-3. PubMed ID: 18516820
[No Abstract] [Full Text] [Related]
20. Editorial commentary: pharmacokinetic variability and tuberculosis treatment outcomes, including acquired drug resistance.
Egelund EF; Peloquin CA
Clin Infect Dis; 2012 Jul; 55(2):178-9. PubMed ID: 22467672
[No Abstract] [Full Text] [Related]
[Next] [New Search]
